Pharmala Biotech Holdings Inc. (CSE: MDMA)

Market Cap	7.39M
Revenue	n/a
Net Income	n/a
Shares Out	86.91M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,010
Open	0.0900
Previous Close	0.0850
Day's Range	0.0850 - 0.0900
52-Week Range	0.0650 - 0.3500
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Pharmala Biotech Holdings

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. The company is headquartered in Vancouver, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Nicholas Kadysh
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MDMA